Sponsor Pipeline

Tyra Biosciences, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
4
Recruiting
3
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT06160752
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating…
Enrollment closed, study ongoing
Active Trials by Phase
Phase 2
3
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06842355 A Study of TYRA-300 in Children With Achondroplasia: BEACH301 Achondroplasia Recruiting
NCT07265947 Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract… Low Grade Upper Tract Urothelial Carcinoma Recruiting
NCT06995677 Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade… Low-grade NMIBC Recruiting
Phase 1/2
NCT05544552 Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma… Locally Advanced Urothelial Carcinoma Active, Not Recruiting
Phase 1
NCT06915753 Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular… Metastatic Hepatocellular Carcinoma Recruiting
NCT06006702 A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet… Healthy Active, Not Recruiting
NCT06160752 Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating… Locally Advanced Cholangiocarcinoma Active, Not Recruiting
Disease Areas
Get alerts when Tyra Biosciences, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free